Hypersensitivity to the active substances or to any of the excipients listed in Description.
Therapy with ATOZET is contraindicated during pregnancy and breast-feeding, and in women of child-bearing potential not using appropriate contraceptive measures (see Use in Pregnancy & Lactation).
ATOZET is contraindicated in patients with active liver disease or unexplained persistent elevations in serum transaminases exceeding 3 times the upper limit of normal (ULN).
ATOZET is contraindicated in patients treated with the hepatitis C antivirals glecaprevir/pibrentasvir.